Neuheit Pharma Technologies

Hyderabad, India Founded: 2013 • Age: 13 yrs
Neuheit Pharma Technologies is engaged in pharmaceutical research and development.

About Neuheit Pharma Technologies

Neuheit Pharma Technologies is a Healthcare company based in Hyderabad (India) founded in 2013 by Venkateswarlu Vobalaboina. Neuheit Pharma Technologies is engaged in pharmaceutical research and development. It operates on a Professional Services model. The company has 45 employees. Its Indian entity Neuheit Pharma Technologies Private Limited reported revenue of β‚Ή18.44 Cr. Neuheit Pharma Technologies offers products and services including Formulation Development, Platform Technologies, 505 (b) (2) Development, Derma Products, and Bio Studies. Its focus areas include Pharmaceuticals and Drug Development.

Company details

Neuheit Pharma Technologies Private Ltd, based in Hyderabad, India, is focused on the research and development of pharmaceutical drug products for global regulated markets. The company is involved in creating complex generic and differentiated products from ideation to commercialization. Services offered include formulation development, platform technology analysis, 505(b)(2) product strategies, and bioequivalence studies. Expertise is provided in solid oral formulations, derma products, and bio-studies, catering to the pharmaceutical sector with innovative approaches and consultancy.

  • Headquarters Hyderabad, India
  • Employees 45
  • Founders Venkateswarlu Vobalaboina
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website neuheitpharma.com
  • Social LinkedIn Facebook
  • Legal Name Neuheit Pharma Technologies Private Ltd
  • Date of Incorporation 03 Sep, 2013
  • Jurisdiction Patancheru, Telangana, India
Key Metrics
  • Annual Revenue
    ₹18.44 Cr

    FY 2025 · +13% YoY

  • Net Profit
    ₹4.69 Cr

    FY 2025 · 25% margin

  • EBITDA
    ₹6.52 Cr

    FY 2025 · 35% margin

  • Employee Count
    45

Products & Services of Neuheit Pharma Technologies

Neuheit Pharma Technologies offers a comprehensive portfolio of products and services, including Formulation Development, Platform Technologies, 505 (b) (2) Development, Derma Products, and Bio Studies.

Formulation Development
Pharmaceutical R&D

Tablets are developed for immediate and sustained release.

Platform Technologies
Pharmaceutical R&D

Technologies are analyzed for intellectual property and efficiency.

505 (b) (2) Development
Pharmaceutical R&D

Reports are provided for 505 B2 product selection.

Derma Products
Pharmaceutical R&D

Derma products are developed for local systemic actions.

Bio Studies
Pharmaceutical R&D

Bio studies are designed for product behavior analysis.

Board of directors of Neuheit Pharma Technologies Private Limited (Neuheit Pharma Technologies)

Neuheit Pharma Technologies Private Limited is the primary company behind Neuheit Pharma Technologies. The board of Neuheit Pharma Technologies Private Limited currently have 2 directors; the longest-serving is Venkateswarlu Vobalaboina, appointed in 2013. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Venkateswarlu Vobalaboina
DIN 06622679
Managing Director03 Sep 201313 yrs 1 moNeuheit Pharma Technologies Private Limited
Vamshi Krishna Vobalaboina
DIN 08876830
Director14 Sep 20206 yrs 1 moNeuheit Pharma Technologies Private Limited

People of Neuheit Pharma Technologies

1 people are tracked at Neuheit Pharma Technologies (1 in leadership); the tracked headcount is 45.

NameRoleGroup
Co-Founder & Managing DirectorLeadership
Premium access

Complete people profiles for Neuheit Pharma Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Neuheit Pharma Technologies

Figures of Neuheit Pharma Technologies Private Limited, the primary company behind Neuheit Pharma Technologies, for FY 2025. Revenue was ₹18.44 Cr (+13% year on year). Net profit was ₹4.69 Cr (25% margin). EBITDA was ₹6.52 Cr (35% margin). Revenue has grown at a compounded annual rate of +31% over three years and +35% over five years.

  • ₹18.44 CrRevenue · FY 2025 · +13% YoY
  • ₹4.69 CrNet profit · 25% margin
  • ₹6.52 CrEBITDA · 35% margin
  • ₹2.93 CrPaid-up capital
  • 45Employees (provident fund records)
  • +31%Revenue CAGR, 3 years
  • +35%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Neuheit Pharma Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Neuheit Pharma Technologies

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Neuheit Pharma Technologies (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M5,180
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.21 B25,870
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Neuheit Pharma Technologies

Neuheit Pharma Technologies was founded in 2013.

Neuheit Pharma Technologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Neuheit Pharma Technologies has 45 employees.

The primary company behind Neuheit Pharma Technologies, Neuheit Pharma Technologies Private Limited, reported revenue of β‚Ή18.44 Cr for FY 2025, up 13% year on year.

Neuheit Pharma Technologies Private Ltd, based in Hyderabad, India, is focused on the research and development of pharmaceutical drug products for global regulated markets. The company is involved in creating complex generic and differentiated products from ideation to commercialization. Services offered include formulation development, platform technology analysis, 505(b)(2) product strategies, and bioequivalence studies. Expertise is provided in solid oral formulations, derma products, and bio-studies, catering to the pharmaceutical sector with innovative approaches and consultancy.

Neuheit Pharma Technologies offers Formulation Development, Platform Technologies, 505 (b) (2) Development, Derma Products, and Bio Studies.

Neuheit Pharma Technologies operates through Neuheit Pharma Technologies Private Limited.

The legal entities of Neuheit Pharma Technologies currently have 2 directors, including Vamshi Krishna Vobalaboina, Venkateswarlu Vobalaboina.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available